How Does Vyleesi Work? Mechanism of Action Explained in Plain English

Vyleesi (bremelanotide) is classified as a melanocortin receptor (MCR) agonist — and if that phrase means nothing to you, you're not alone. Understanding how Vyleesi actually works can help you make sense of why it helps with low sexual desire, why it's injected rather than taken as a pill, and why its side effects look the way they do.

Here's the full explanation in plain English.

The Biology of Sexual Desire: It Starts in the Brain

Sexual desire isn't primarily driven by hormones or body parts — it originates in the brain. Specifically, areas of the central nervous system (CNS) regulate what we think of as the "excitatory" and "inhibitory" pathways for desire. When excitatory pathways are active, desire increases. When inhibitory pathways dominate, desire decreases or disappears.

Hypoactive sexual desire disorder (HSDD) is thought to involve an imbalance — too much inhibition or not enough excitation — in these brain pathways. Vyleesi works on the excitatory side of this equation.

What Is a Melanocortin Receptor?

Melanocortin receptors (MCRs) are a family of protein receptors found throughout the brain and body. There are five subtypes (MC1R through MC5R). These receptors are activated by naturally occurring molecules called melanocortins — peptides derived from a protein called POMC (pro-opiomelanocortin).

Different MCR subtypes have different functions:

• MC1R: Found on melanocytes (pigment cells in skin). When activated, it increases melanin production, which causes skin darkening. This is why Vyleesi can cause hyperpigmentation as a side effect.
• MC4R: Found in many areas of the CNS. Neurons with MC4R are present throughout the brain and are associated with appetite regulation, energy balance — and sexual desire.

How Vyleesi (Bremelanotide) Activates These Receptors

Bremelanotide is a synthetic peptide — a small chain of amino acids — designed to mimic naturally occurring melanocortins. When you inject Vyleesi, the bremelanotide travels through your bloodstream and crosses into the central nervous system, where it binds to and activates melanocortin receptors — primarily MC1R and MC4R.

The activation of MC4R receptors in the brain is believed to engage excitatory pathways involved in sexual motivation and desire. The precise molecular mechanism by which this improves HSDD isn't fully understood — the FDA prescribing information itself states that "the mechanism by which VYLEESI improves HSDD in women is unknown." But the clinical evidence that it works for many patients is well established from Phase 3 trials.

How Is This Different From Addyi and Hormonal Treatments?

There are three main approaches to treating HSDD:

1. Melanocortin pathway (Vyleesi): Activates MC4R receptors in the CNS to stimulate excitatory sexual desire pathways. On-demand, injected.
2. Serotonin/dopamine/norepinephrine modulation (Addyi): Flibanserin acts as a serotonin agonist/antagonist, recalibrating neurotransmitter balance over time. Daily pill, takes weeks to work.
3. Hormonal approach (testosterone): Off-label testosterone supplementation raises hormone levels that support libido. Works on hormonal biology rather than brain receptor activation.

Vyleesi's brain-first approach is entirely non-hormonal. It doesn't change your estrogen, progesterone, or testosterone levels. Instead, it directly activates the neural pathways that generate desire, making it unique among available treatments.

Why Does Vyleesi Need to Be Injected?

Bremelanotide is a peptide, which means it would be broken down by stomach acids and digestive enzymes if you took it as a pill. Injecting it subcutaneously (just under the skin) allows it to be absorbed directly into the bloodstream, maintain its chemical structure, and reach the brain intact. This is why injectables are often used for peptide-based medications.

Why Does Vyleesi Cause Nausea and Blood Pressure Changes?

Bremelanotide doesn't selectively activate only MC4R — it also activates other melanocortin receptor subtypes, including MC1R (causing flushing and potential skin darkening), and receptors involved in nausea and blood pressure regulation. These off-target effects explain:

• Nausea (40% of users): MC receptor activity in the brainstem/GI system
• Flushing (20% of users): vasodilatory effects of MCR activation
• Blood pressure increase / heart rate decrease: cardiovascular effects of MCR activation
• Skin darkening (hyperpigmentation): MC1R activation increases melanin production

For more detail on managing side effects, see our guide to Vyleesi side effects and what to expect.

If you're ready to try Vyleesi, medfinder can help you find a specialty pharmacy near you that can fill your prescription.